Moximed, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Moximed, Inc. - overview
Established
2006
Location
Fremont, CA, US
Primary Industry
Medical Devices & Equipment
About
Based in California, US, and founded in 2006 by co-founders Anton Clifford, Ph. D. , and Joshua Makower, MD, Moximed, Inc. , formerly known as ExploraMed NC, operates as a provider of implantable shock absorbers for knee osteoarthritis to patients looking for non-surgical relief from joint pain and dysfunction.
In August 2024, Moximed, Inc. raised USD 91 million in Series D funding led by Patient Square Capital, LP, with participation from New Enterprise Associates, Future Fund, Advent Life Sciences, Gilde Healthcare Partners, Vertex Ventures HC, GBS Venture Partners, Morgenthaler Ventures, Cormorant Asset Management, and Warren Point Capital. As of 2024, the company is led by its CEO, Christopher Gleason. The company provides a wide range of medical device products, such as the MISHA Knee System, which includes an implantable shock absorber intended to reduce knee pain and improve function.
Additionally, the firm also provides services such as clinical research and patient support for the MISHA Knee System.
Current Investors
New Enterprise Associates, GBS Venture Partners, Gilde Healthcare
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.moximed.com/
Verticals
Manufacturing
Company Stage
Series D
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.